Nifty
:
24213.30
Sensex
:
79476.63
217.95 (0.91%)
694.39 (0.88%)
Nifty
Sensex
:
:
24213.30
79476.63
217.95 (0.91%)
694.39 (0.88%)

Ind-Swift Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 532305 | NSE: INDSWFTLAB

NSE BSE
133.33
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  127.50
  •  134.99
  •  127.37
  •  127.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  969740
  •  1281.51
  •  186.00
  •  89.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 691.61
  • 2.38
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 276.31
  • N/A
  • 0.74

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.00%
  • 16.50%
  • 36.63%
  • FII
  • DII
  • Others
  • 0.65%
  • 0.00%
  • 4.22%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.05
  • 10.56
  • 10.38

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.86
  • 0.93

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.87
  • 11.23

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.64
  • 3.87
  • 11.23

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.87
  • 0.86
  • 0.93

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.78
  • 5.95
  • 4.99

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
33.17
310.34
-89.31%
393.33
304.25
29.28%
287.51
312.69
-8.05%
289.71
310.21
-6.61%
Expenses
42.91
250.04
-82.84%
430.64
240.57
79.01%
235.82
258.92
-8.92%
224.02
251.46
-10.91%
EBITDA
-9.74
60.30
-
-37.30
63.67
-
51.69
53.76
-3.85%
65.70
58.75
11.83%
EBIDTM
-29.37%
19.43%
-9.48%
20.93%
17.98%
17.19%
22.68%
18.94%
Other Income
11.14
5.61
98.57%
25.25
10.21
147.31%
7.11
8.36
-14.95%
7.40
7.54
-1.86%
Interest
0.17
20.38
-99.17%
-11.47
21.82
-
21.05
22.38
-5.94%
21.14
23.98
-11.84%
Depreciation
0.25
13.88
-98.20%
12.67
9.29
36.38%
13.56
15.39
-11.89%
13.19
16.41
-19.62%
PBT
0.98
31.64
-96.90%
373.34
16.13
2,214.57%
24.19
24.35
-0.66%
38.77
25.91
49.63%
Tax
-0.03
14.24
-
134.47
41.17
226.62%
4.67
-3.27
-
6.93
0.56
1,137.50%
PAT
1.01
17.40
-94.20%
238.87
-25.05
-
19.53
27.62
-29.29%
31.83
25.34
25.61%
PATM
3.04%
5.61%
60.73%
-8.23%
6.79%
8.83%
10.99%
8.17%
EPS
0.16
2.92
-94.52%
40.42
-4.25
-
3.29
4.65
-29.25%
5.36
4.29
24.94%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
1,003.72
1,207.31
1,038.73
891.34
779.64
756.60
762.52
697.42
653.25
660.45
965.08
Net Sales Growth
-18.89%
16.23%
16.54%
14.33%
3.05%
-0.78%
9.33%
6.76%
-1.09%
-31.57%
 
Cost Of Goods Sold
599.92
655.59
537.43
451.44
396.66
403.36
390.56
392.19
353.01
407.39
754.92
Gross Profit
403.80
551.73
501.30
439.90
382.98
353.24
371.96
305.24
300.23
253.07
210.16
GP Margin
40.23%
45.70%
48.26%
49.35%
49.12%
46.69%
48.78%
43.77%
45.96%
38.32%
21.78%
Total Expenditure
933.39
978.11
843.11
708.54
636.16
630.48
628.43
591.47
545.97
571.69
906.18
Power & Fuel Cost
-
76.07
58.45
37.31
34.65
37.44
29.58
26.00
22.65
34.78
36.82
% Of Sales
-
6.30%
5.63%
4.19%
4.44%
4.95%
3.88%
3.73%
3.47%
5.27%
3.82%
Employee Cost
-
126.17
117.40
97.86
95.92
90.98
88.12
69.65
62.76
50.65
44.95
% Of Sales
-
10.45%
11.30%
10.98%
12.30%
12.02%
11.56%
9.99%
9.61%
7.67%
4.66%
Manufacturing Exp.
-
43.41
40.85
64.24
59.30
50.06
63.50
43.40
38.56
30.13
26.35
% Of Sales
-
3.60%
3.93%
7.21%
7.61%
6.62%
8.33%
6.22%
5.90%
4.56%
2.73%
General & Admin Exp.
-
38.17
36.03
27.17
27.58
27.27
28.69
23.33
21.54
20.33
22.37
% Of Sales
-
3.16%
3.47%
3.05%
3.54%
3.60%
3.76%
3.35%
3.30%
3.08%
2.32%
Selling & Distn. Exp.
-
37.29
39.03
28.74
21.65
21.30
27.92
29.06
28.87
28.33
13.95
% Of Sales
-
3.09%
3.76%
3.22%
2.78%
2.82%
3.66%
4.17%
4.42%
4.29%
1.45%
Miscellaneous Exp.
-
1.42
13.93
1.77
0.40
0.07
0.06
7.86
18.57
0.09
13.95
% Of Sales
-
0.12%
1.34%
0.20%
0.05%
0.01%
0.01%
1.13%
2.84%
0.01%
0.71%
EBITDA
70.35
229.20
195.62
182.80
143.48
126.12
134.09
105.95
107.28
88.76
58.90
EBITDA Margin
7.01%
18.98%
18.83%
20.51%
18.40%
16.67%
17.59%
15.19%
16.42%
13.44%
6.10%
Other Income
50.90
33.50
43.50
22.71
33.46
36.91
25.82
22.62
15.91
22.25
14.17
Interest
30.89
92.17
95.55
100.22
106.65
92.24
35.38
90.27
106.42
117.29
116.66
Depreciation
39.67
57.36
131.04
87.29
90.06
104.05
86.62
88.26
84.75
84.29
65.77
PBT
437.28
113.17
12.53
18.01
-19.77
-33.26
37.92
-49.96
-67.98
-90.56
-109.35
Tax
146.04
38.69
14.68
21.16
1.42
20.73
14.01
-16.17
-24.09
-23.98
-20.05
Tax Rate
33.40%
44.72%
117.16%
117.49%
-7.18%
41.73%
38.94%
29.24%
29.10%
16.73%
14.11%
PAT
291.24
47.83
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
-119.37
-122.01
PAT before Minority Interest
291.24
47.83
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
-119.37
-122.01
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
29.02%
3.96%
-0.21%
-0.35%
-2.72%
3.83%
2.88%
-5.61%
-8.98%
-18.07%
-12.64%
PAT Growth
542.77%
-
-
-
-
31.71%
-
-
-
-
 
EPS
49.28
8.09
-0.36
-0.53
-3.59
4.90
3.72
-6.62
-9.93
-20.20
-20.64

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
681.93
600.97
603.51
640.64
587.81
553.24
531.32
517.43
594.85
725.23
Share Capital
59.81
59.81
59.81
59.81
48.29
46.00
45.46
41.68
41.68
40.96
Total Reserves
622.12
541.17
543.70
580.83
539.53
505.69
483.39
475.74
553.17
674.95
Non-Current Liabilities
741.18
813.57
840.15
828.33
901.32
437.80
494.76
717.24
811.33
983.36
Secured Loans
752.60
847.78
884.13
885.96
953.86
503.97
563.69
666.84
723.03
862.23
Unsecured Loans
0.00
0.00
0.00
4.93
11.72
16.52
28.32
79.48
93.11
102.17
Long Term Provisions
17.79
17.03
15.73
14.76
14.34
13.32
9.16
0.00
0.00
0.00
Current Liabilities
371.09
334.47
314.52
323.07
356.00
935.93
1,005.02
950.81
832.82
630.01
Trade Payables
203.99
175.95
138.82
135.23
126.68
128.64
102.36
132.43
134.11
213.71
Other Current Liabilities
105.67
89.10
81.29
72.92
136.49
490.25
496.93
314.60
248.67
21.50
Short Term Borrowings
49.17
64.03
93.43
114.93
92.52
311.31
405.70
503.66
450.05
390.97
Short Term Provisions
12.25
5.39
0.98
0.00
0.31
5.73
0.03
0.12
0.00
3.83
Total Liabilities
1,794.20
1,748.90
1,758.09
1,792.04
1,845.13
1,926.97
2,031.10
2,185.48
2,239.00
2,338.60
Net Block
585.04
627.53
738.65
843.14
901.20
924.59
1,032.56
1,098.73
1,116.82
1,173.77
Gross Block
1,330.92
1,316.68
1,302.04
1,359.32
1,378.95
1,349.27
1,406.84
1,420.51
1,404.21
1,405.28
Accumulated Depreciation
745.88
689.15
563.38
516.18
477.75
424.68
374.28
321.78
287.40
231.51
Non Current Assets
629.68
673.56
813.91
929.00
1,009.05
1,087.71
1,202.46
1,263.78
1,319.18
1,349.72
Capital Work in Progress
7.71
10.31
18.84
11.45
19.87
68.60
70.26
78.47
112.83
78.10
Non Current Investment
30.34
29.06
35.53
17.45
31.03
31.02
31.09
17.63
17.52
17.07
Long Term Loans & Adv.
4.17
3.96
6.11
56.95
56.95
63.50
54.24
68.96
72.00
80.78
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
14.31
0.00
0.00
0.00
Current Assets
1,163.12
1,073.32
941.88
863.03
836.09
839.26
828.64
921.70
919.82
988.89
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
438.60
428.50
375.67
342.82
316.61
316.91
343.56
356.02
348.31
377.03
Sundry Debtors
505.32
454.78
432.39
396.45
350.85
407.76
357.27
372.45
389.04
443.85
Cash & Bank
18.20
21.48
11.60
10.58
29.97
9.45
16.13
22.58
19.84
20.59
Other Current Assets
201.00
16.92
56.33
38.73
138.66
105.14
111.69
170.66
162.64
147.41
Short Term Loans & Adv.
191.98
151.64
65.90
74.45
96.84
92.09
95.37
157.41
144.03
126.33
Net Current Assets
792.03
738.86
627.36
539.96
480.08
-96.67
-176.37
-29.11
87.01
358.87
Total Assets
1,792.80
1,746.88
1,755.79
1,792.03
1,845.14
1,926.97
2,031.10
2,185.48
2,239.00
2,338.61

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
194.62
150.27
134.95
125.24
-64.40
73.09
95.57
79.43
98.40
65.53
PBT
113.17
12.53
18.01
-19.77
-33.26
37.87
-49.96
-67.98
-90.57
-109.35
Adjustment
132.78
225.66
179.35
176.02
186.26
103.64
167.95
186.30
169.93
144.59
Changes in Working Capital
-51.33
-87.92
-62.41
-31.01
-214.80
-68.41
-22.42
-38.89
22.87
39.54
Cash after chg. in Working capital
194.62
150.27
134.95
125.24
-61.80
73.09
95.57
79.43
102.23
74.78
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
-2.60
0.00
0.00
0.00
-3.83
-9.25
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-13.37
4.77
-10.17
-9.10
-12.47
-17.40
-30.94
-29.56
-35.61
-27.39
Net Fixed Assets
-12.34
-8.59
50.42
31.26
19.05
59.23
21.87
18.07
-34.69
29.24
Net Investments
25.56
-55.35
-28.97
12.52
0.24
0.23
-12.97
-0.05
0.88
0.06
Others
-26.59
68.71
-31.62
-52.88
-31.76
-76.86
-39.84
-47.58
-1.80
-56.69
Cash from Financing Activity
-185.66
-140.88
-123.75
-133.26
99.62
-61.98
-68.90
-47.92
-63.72
-37.76
Net Cash Inflow / Outflow
-4.41
14.17
1.03
-17.12
22.76
-6.30
-4.27
1.94
-0.94
0.38
Opening Cash & Equivalents
21.48
11.60
10.58
29.97
9.45
16.13
22.58
19.84
20.59
18.28
Closing Cash & Equivalent
17.07
25.77
11.61
10.58
29.97
9.45
16.13
21.78
19.84
20.59

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
84.25
68.33
66.35
70.21
73.01
65.58
58.08
56.78
67.21
93.07
ROA
2.70%
-0.12%
-0.18%
-1.17%
1.53%
1.11%
-1.86%
-2.65%
-5.22%
-5.18%
ROE
10.61%
-0.54%
-0.78%
-5.56%
8.99%
7.89%
-15.89%
-23.11%
-36.36%
-27.88%
ROCE
13.25%
7.88%
8.31%
5.97%
9.25%
4.59%
2.19%
1.40%
-1.52%
-1.46%
Fixed Asset Turnover
0.92
0.80
0.67
0.57
0.56
0.56
0.51
0.48
0.48
0.71
Receivable days
144.51
154.46
168.41
174.12
182.19
181.25
185.94
206.44
223.20
158.98
Inventory Days
130.51
140.01
145.99
153.65
152.15
156.48
178.26
190.95
194.38
153.77
Payable days
105.77
106.89
110.78
68.85
63.73
60.79
64.19
12.73
29.95
80.99
Cash Conversion Cycle
169.25
187.58
203.62
258.91
270.60
276.94
300.00
384.67
387.63
231.76
Total Debt/Equity
1.71
2.33
2.56
2.48
3.21
4.38
4.77
6.25
5.12
3.56
Interest Cover
1.94
1.13
1.18
0.81
1.54
2.02
0.39
0.22
-0.22
-0.22

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Ind-Swift Laboratories sets up new marketing office in New Delhi
    23rd Sep 2024, 11:19 AM

    The Delhi office is specifically designed to lead and drive marketing efforts for its Ethical Pharma Business and manage field sales force

    Read More
  • Ind-Swift Lab. - Quarterly Results
    12th Aug 2024, 19:44 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.